Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM

This study has been completed.
Keryx / AOI Pharmaceuticals, Inc.
Information provided by:
Duke University Identifier:
First received: January 29, 2008
Last updated: July 15, 2014
Last verified: January 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2008
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)